MORE ARTICLES
- Migration to Massachusetts in 2022: Where Are People Going?July 18, 2024 - 3:00 pm
- The Economic Development Bill Starting to Take Shape; It Makes Big Bets on Life Sciences, Clean Technology and Applied AIJuly 18, 2024 - 2:11 pm
- Disparities in LIHTC Data Illuminate Difficulties in Housing ProductionJuly 18, 2024 - 12:13 pm
- Examining the New Massachusetts Estate TaxJuly 18, 2024 - 9:43 am
- Study: U.S. Immigration System Limits Benefits Foreign Students Could ProvideJuly 17, 2024 - 5:33 pm
- Pulitzer Winner Kai Bird on Robert Oppenheimer & the Atomic BombJuly 17, 2024 - 11:21 am
- Candidate Selection Breakdown: Presidential Primary Primacy or Determined Delegate DetourJuly 16, 2024 - 4:53 pm
- Massachusetts is Losing Thousands of Taxpayers a Year. Where Are They Going?July 16, 2024 - 10:13 am
- At a Glance: Who Moved to Massachusetts in 2022? July 11, 2024 - 4:03 pm
- Do No Harm to the Health Policy CommissionJuly 11, 2024 - 3:51 pm
Stay Connected!
Receive the latest updates in your inbox.
Boston Children’s, MGH Among Massachusetts Hospitals with Highest Relative Commercial Prices
/in Featured, Health Care, Health Care Policy (MA), Healthcare, News, Pioneer Research /by Editorial StaffPioneer Institute’s new tool, the Massachusetts Hospital Relative Price Tracker, displays relative price and facilitates relative price comparisons among hospitals. The average price among all hospitals will have a relative price of 1.0. A relative price of 1.5 means that a hospital charges 50 percent higher than the average of all Massachusetts hospitals. Similarly, a relative price of 0.84 means that a hospital’s prices are 16 percent below average. Relative price data is collected and reported by the Commonwealth’s Center for Health Information and Analysis (CHIA) and is an aggregate measure used to evaluate price variations among different hospitals. It is recalculated annually based on data collected from commercial payers and includes information on private commercial insurance and commercially managed public insurance products such as Medicare Advantage and Medicaid Managed Organizations/Accountable Care Partnership Plans.
Yale University Pulitzer Winner Beverly Gage on J. Edgar Hoover & the FBI
/in Education, Featured, Learning Curve, News, Podcast /by Editorial StaffYale Prof. Beverly Gage, author of “G-Man: J. Edgar Hoover and the Making of the American,” delves into the enigmatic life and career of J. Edgar Hoover, tracing his formative years in Washington, D.C., his rise to prominence as director of the FBI, and his enduring influence on American law enforcement and politics.
Mortgage’s New Normal: Guide to Better Borrowing Amidst Higher Rates
/in Featured, News, Podcast Hubwonk /by Editorial StaffJoe Selvaggi talks with mortgage expert, Trip Miller of Cambridge Savings Bank, about mortgage rates and trends and explores best practices for finding a mortgage structure that suits individual buyers’ needs.
Study: Ed Reform Has Improved Academic Performance and Equity
/in Education, Featured, Pioneer Research /by Editorial StaffOver the past 30 years, rigorous standards, assessments, and accountability for outcomes have propelled Massachusetts public schools to become the nation’s best. Taking away the high-stakes component of MCAS would weaken the accountability system and lead stakeholders to de-emphasize the assessment data that drives high-quality instruction, according to a new study published by Pioneer Institute.
UK U-Warwick’s Benjamin Smith on Mexico’s Cartels & Drug Trade
/in Education, Featured, Learning Curve, News, Podcast /by Editorial StaffProf. Benjamin Smith, author of The Dope: The Real History of the Mexican Drug Trade, provides insights into various aspects of the Mexican drug trade, including its historical context and the evolution of illicit drug products over time. He discusses key cartels and their methods, the impact of the drug trade on Mexico’s murder rates, the immense financial scale of the trade, its effect on Mexico and the U.S., and the challenges law enforcement face in combating it. Smith explores the relationship among Mexican cartels, other foreign countries, and the illicit drug market in the U.S.